BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 49.45
+0.25 (0.51%)
At close: Mar 6, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 3.46 billion as of March 6, 2026. Its market cap has decreased by -15.76% in one year.
Market Cap
3.46B
Enterprise Value
2.33B
Revenue
105.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
49.45
Market Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 3.46B, a decrease of -9.27%. That is a compound annual growth rate of -7.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 3.44B | -12.46% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shiny Brands Group | 3.48B |
| Kura Sushi Asia | 3.47B |
| Zen Voce | 3.46B |
| Cystech Electronics | 3.46B |
| Sagittarius Life Science | 3.46B |
| Tian Zheng International Precision Machinery | 3.44B |
| Accordance Systems | 3.43B |
| LFA Co., Ltd. | 3.41B |